The Sidney R. Knafel Page

The Knafel Center for Government and International Studies at Harvard

Knafel donated $20 million to Harvard University to build a complex that is intended to be "a hub for the social sciences." He is currently the chairman of the Overseers' Visiting Committee to the Center for International Affairs. (The Harvard University Gazette, 1996 Nov. 21.)

Knafel Center / Harvard Gazette 1996

Knafel has been a director of IGENE since 1982, and Thomas L. Kempner of Loeb Partners has been a fellow director since 1981.

IGENE 2002 DEF 14A / Securities and Exchange Commission

BioReliance (formerly Microbiological Associates)

Established in 1947, the company got its first contracts with the National Institutes of Health and the National Cancer Institute in the latter 1950s. The Whittaker Corp. acquired MA in 1969, and during the 1970s it became the largest contractor to the NCI, as well as serving the FDA, EPA, USDA and DoD. The company is presently "the principal provider for development and manufacturing services supporting the US Department of Defense Smallpox Vaccine Biodefense Program." "Sales to the US government represented 8%, 11% and 11% of consolidated revenue in 1998, 1999 and 2000, respectively."

In 1984, MA was acquired by Daryl Laboratories, principally owned by Sidney R. Knafel, who became its chairman. Knafel was founder, chairman and equity holder of Vision Cable until its sale in 1981, followed by chairman of the board of Insight Communications Co. since 1985. Victoria Hamilton of the Lasker-associated Washington Advisory Group is a member of the board of BioReliance, and has been a principal in Knafel's SRK Management Co. since 1982.

Company History / BioReliance

Knafel owns about 35%, with another 11-14% in trusts. Knafel's brother-in-law, Leonard Scherlis MD, professor emeritus of medicine at the University of Maryland Medical School, who served as a research professor in the school's Department of Epidemiology and Preventive Medicine from 1987 to 1998, has served on the board with him since 1982. Victoria Hamilton has also been a principal of SRK Associates and a director of BioReliance since 1982. Three of the six directors (Gedale, Hamilton and Knafel) are or have been on the board of directors of General American Investors.

BioReliance 2002 DEF 14A / Securities and Exchange Commission

Robert J. Huebner of the National Cancer Institute's Special Virus Cancer Program funded work by MA on RNA tumor viruses in animals while he was a member of the CTR Scientific Advisory Board. (Draft, 9/1/71, RNA Tumor Virus Genomes as Determinants of Chemically Induced Transformation in Vitro. Aaron E. Freeman, Paul J. Price, Eugene M. Zimmerman, Gary J. Kalloff, Robert J. Huebner.) Freeman and Huebner published at least 19 studies between 1966 and 1978. CTR Research Director Vincent F. Lisanti said that Huebner steered CTR funding toward MA's mouse study.

Freeman et al, 1971 / UCSF (pdf, 14 pp)

The official fairy tale concerning Microbiological Associates: "The Council for Tobacco Research contracted with Microbiological Associates to do the world's largest inhalation study, involving more than 10,000 mice in 1973-1982... Per Dr. Carol Henry, Microbiological Associates' director of inhalation toxicology, the lab initially had considerable freedom, but after nine years of work and $12 million, the team was told in 1982 that it could no longer meet with CTR staffers unless a lawyer was present. Dr. Henry told them it was unacceptable, and a CTR lawyer told them that is the way it is. The lab knuckled under. If the contract was canceled before the first experiment was completed, 40 staffers might lose their jobs and nine years' worth of data would never come to light (WSJ 2/11/93)." (Microbiological Associates Profile, Tobacco Documents Online, 6/10/03. Link died The deceit here is in pretending that this study had any scientific value in smoking and health. It was a pure ripoff, which the Lasker Syndicate's stooges in the media spin-doctored into a supposed outrage. Also, if the CTR had wished to suppress research, it would have been much simpler not to have given them $12 million in the first place.

After leaving MA, Carol J. Henry became Chief of Toxicology of ICF Incorporated, which in 1988 handled the illegal pass-through contracts to anti-smoking activists to write the key chapters of the EPA's ETS report. In 1993, she was at the California EPA as Director of Proposition 65 Implementation, and in 1998 testified for the anti-smokers in an ETS personal injury suit.

Victoria Hamilton

Victoria Hamilton was a principal of Knafel's SRK Management Company plus a director of BioReliance since 1982. She was vice-president of General American Investors from 1992 to 1995, and a director from 1996 to December 1998. She has been a principal of the Lasker-associated Washington Advisory Group since 1996.

William J. Gedale

Gedale has been a director of BioReliance since 1991. He was the President and CEO of General American Investors from 1989 to 1995. Mary Lasker's longtime correspondent Frank Altschul was the first president of this firm when it was founded in 1927, and later its chairman from 1948 to 1961. Knafel has been a director since 1994, and fellow directors include Lewis B. Cullman, brother of Philip Morris Chairman-for-Life Joseph Cullman.

Source Media

Board of Directors / Source Media

<= Back to The Lasker Syndicate

cast 07-23-06